# Stage 2V — Gate 0 Reassessment and Stage Completion Report

**Stage:** 2V (record the owner's A-1 affirmation; reassess Gate 0 status)
**Status:** complete — affirmation recorded; `R-17` **S**; `B-07` closed; Gate 0 **not passed**
**Authorizes:** nothing

---

## 1. Owner affirmation recorded

Statement, verbatim (see `STAGE2V_A1_OWNER_AFFIRMATION_RECORD.md` §1):

> I ratify docs/research/stage2u/STAGE2U_A1_SIGNED_OWNER_DECISION_RECORD_DRAFT.md, SHA256 7d307a2329fd936d2f04471a8d58017ea93d0d1d8018c9c13e4b53abab6f358f, dated 2026-11-11.

Date: **2026-11-11** (owner-authored). The ratified A-1 was not edited; the signature is captured in
a new record that binds the frozen text by hash. The earlier `confirmed.` reply was assessed as
insufficient and had no effect (recorded in the affirmation record §3).

---

## 2. Checklist after this stage — 16 S / 4 P / 0 O / 1 B / 2 N/A

Only one row changed: **`R-17` P → S**. No other row moved.

- **S (16):** R-01, R-02, R-03, R-04, R-07, R-09, R-11, R-12, R-13, R-14, R-16, **R-17**, R-18,
  R-19, R-20, R-21.
- **P (4):** R-05 (venue executability — Gate 1), **R-08** (real-capital sizing — T-4 deferred),
  R-10 (venue/cost evidence — Gate 1), R-22 (no reviewer — Gate 4).
- **B (1):** R-15 — testable for the research leg; **blocked for any real-capital claim**.
- **N/A (2):** R-06, R-23.

`R-13` stays **S** because it concerns the decisions D-01…D-15, all resolved; the deferred item is
the Stage 2T decision **T-4**, which is tracked by R-08, not by R-13.

---

## 3. Blockers after this stage

- **`B-07` (Gate 0 artifact consolidation) → closed.** All four artifacts now exist: A-1 signed
  (Stage 2V), A-2/A-3/A-4 ratified (T-1/T-2/T-3, 2026-11-11). Closure covers consolidation only.
- Closed: B-01, B-08, B-09.
- `B-02` open, narrowed (owner statement; per-capability venue evidence unmet); B-03, B-04, B-05,
  B-06, B-10, B-11 open; B-12 recorded, not actionable.

**Decision register:** D-01…D-15 unchanged in value; D-15 remains deferred.

---

## 4. Gate 0 verdict — NOT PASSED

Gate 0 inputs `I-1` (owner-supplied `$100` real capital), `I-6` (frequency acknowledgment, `R-21` S)
and `A-1`–`A-4` now all exist. Gate 0 nevertheless does **not** pass:

1. **R-08 P** — the real-capital per-trade sizing convention is deferred (T-4); no risk amount or
   percentage exists on the real base.
2. **R-15 B** — the owner's real-capital objective (`$250` on `$100` = `250%/year`) is therefore not
   in a form a future experiment can test; only the `$10,000` research-leg objective is.
3. `R-05` / `R-10` P and `R-22` P are Gate 1 / Gate 4 items; they do not block Gate 0 but keep it
   from being "ready" in any broader sense.

Gate 0 would pass on the real-capital objective only after a separately authorized T-4 decision. It
cannot pass on the research leg alone while the owner's stated objective is the real-capital one.

---

## 5. Validation

- A-1 recomputed SHA256 `7d307a23…6358f`, 10,023 bytes = the hash/bytes the owner named = the Stage
  2U manifest entry; git blob `22d42b70…9ccb1a`; unchanged since `0e6c209`.
- No historical artifact, A-1, Stage 2U manifest, or predecessor manifest modified; `git diff`
  confined to `docs/research/stage2v/`.
- Stage 2V freeze manifest re-verifies its two deliverables, its sources, and all seven predecessor
  manifests (2M 27, 2P 16, 2Q 15, 2R 10, 2S 21, 2T 23, 2U 2/23 entries) with zero mismatches.

---

## 6. Repository state

| item | value |
|---|---|
| branch | `main` |
| starting HEAD | `81f165d` `docs(stage2u): add freeze manifest` |
| commits | the affirmation record, this report, and the Stage 2V freeze manifest (hashes in the final report) |
| ending HEAD | the freeze-manifest commit |
| push | `origin/main`, verified after validation |

---

## 7. Scope confirmations

No market-data access or processing; no census, backtest, simulation, expectancy, or P&L; no strategy
design; no venue contact or venue claim; no cost/liquidity/execution study; no real-capital sizing;
no paper or live trading; no Gate 0 passage; no Gate 1–5 progression; no Stage 2W. D-01…D-15, frozen
thresholds, and cost assumptions unchanged; the R-17 wording discrepancy preserved. The `$100` real
capital, `$30` tolerance, `$1`–`$3` notional, T-4 deferral, and `$250`/`$100` objective are unchanged
and unvalidated.
